Anticipated Stigma, Illness Identity, and Quality of Life in Male Hypogonadism

Sponsor
Hacettepe University
Study ID
NCT07752511
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study aims to systematically compare the levels of anticipated illness stigma and illness identity among men diagnosed with hypogonadism to those of men with other chronic endocrine conditions (e.g., diabetes mellitus, hypothyroidism, and hypertension). Furthermore, it examines whether these psychosocial variables predict quality-of-life deterioration specifically within the hypogonadism cohort.

Key Dates

First listed
Aug 7, 2026
Start date
Oct 1, 2026
Status verified
Aug 2026
Primary completion
Oct 20, 2027
Completion
Oct 30, 2027

Study Design

Enrollment
90 participants (estimated)

Arms

  • Arm: Hypogonadism Group (Case)
    Male patients aged 18 years or older with biochemically confirmed hypogonadism (total testosterone \< 300 ng/dL with at least one clinical symptom) undergoing regular follow-up in the endocrinology clinic.
  • Arm: Control Group (Other Chronic Endocrine Diseases)
    Male patients aged 18 years or older diagnosed with diabetes mellitus, hypertension, or hypothyroidism without hypogonadism (total testosterone ≥ 300 ng/dL), matched by age (±5 years) to the case group and under regular follow-up in the same endocrinology clinic.

Primary Outcome Measure

Chronic Illness Anticipated Stigma Scale (CIASS) Score [ Time Frame: Baseline (Single session, day 1) ]

Find similar trials

Nationwide
Hypertension (high blood pressure) trialsCardiology trialsHeart disease trials

Related Studies